Necessity of concurrent chemotherapy in N2‐3 nasopharyngeal carcinoma treated with neoadjuvant chemotherapy of ≥3 cycles followed by intensity‐modulated radiotherapy

Concurrent chemotherapy (CCT) is used in locally advanced nasopharyngeal carcinoma (NPC) for improved local control, which could also be achieved by intensity‐modulated radiotherapy (IMRT). And for N2‐3 NPC, distant metastasis is the more important cause of death. This study aims to evaluate the val...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Hui, Peng, Liang, Tao, Ya‐Lan, Chen, Chen, Xiao, Wei‐Wei, Hu, Yong‐Hong, Gao, Yuan‐Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558596/
https://www.ncbi.nlm.nih.gov/pubmed/31006996
http://dx.doi.org/10.1002/cam4.2179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558596/
https://www.ncbi.nlm.nih.gov/pubmed/31006996
http://dx.doi.org/10.1002/cam4.2179

Ejemplares similares